Quick Answer
aTYR PHARMA INC reported Total Assets of $93.00 million for the year ending 2025.
- aTYR PHARMA INC showed a decrease of -4.0% in Total Assets from 2024 to 2025.
- This data is from aTYR PHARMA INC's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $59.91 million | Q2 2015: $153.08 million | Q3 2015: $141.37 million | Q1 2016: $115.13 million | Q2 2016: $100.49 million | Q3 2016: $85.93 million | Q1 2017: $65.74 million | Q2 2017: $61.47 million | Q3 2017: $94.49 million | Q1 2018: $78.47 million | Q2 2018: $68.31 million | Q3 2018: $59.77 million | Q1 2019: $49.92 million | Q2 2019: $48.76 million | Q3 2019: $43.75 million | Q1 2020: $54.45 million | Q2 2020: $47.56 million | Q3 2020: $41.64 million | Q1 2021: $55.13 million | Q2 2021: $49.00 million | Q3 2021: $123.92 million | Q1 2022: $104.78 million | Q2 2022: $96.02 million | Q3 2022: $96.06 million | Q1 2023: $136.84 million | Q2 2023: $132.75 million | Q3 2023: $125.07 million | Q1 2024: $113.25 million | Q2 2024: $105.94 million | Q3 2024: $91.62 million | Q1 2025: $97.25 million | Q2 2025: $101.53 million | Q3 2025: $106.65 million.
- Over the full 12 years of available data (2014 to 2025), aTYR PHARMA INC's Total Assets has grown by 350.5%.
- Historical annual values: Fiscal year 2025: $93.00 million | Fiscal year 2024: $96.83 million | Fiscal year 2023: $120.65 million | Fiscal year 2022: $95.79 million | Fiscal year 2021: $115.54 million | Fiscal year 2020: $38.73 million | Fiscal year 2019: $36.19 million | Fiscal year 2018: $52.75 million | Fiscal year 2017: $89.36 million | Fiscal year 2016: $80.52 million | Fiscal year 2015: $129.68 million | Fiscal year 2014: $20.64 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: